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Available online xxxxBackground: Left ventricle diastolic dysfunction (LVDD) is a common ﬁnding in high risk individuals, its presence
being associated with reduced exercise capacity (EC). We assessed the prevalence of LVDD, applying the 2016
guidelines of the American Society of Echocardiography (ASE)/European Association of Cardiovascular Imaging
(EACVI), in a population with overweight/obesity and metabolic syndrome and its association with EC.
Methods and results: This was a prospective, cross-sectional study of a cohort of 235 patients (mean age of 65 ±
5 years old and 33% female) without heart disease and an ejection fraction N50% who underwent a complete
echocardiographic assessment and cardiopulmonary exercise testing. Individuals meeting three or more criteria
of the 2016ASE/EACVI guidelines are considered to have LVDD,while tests are considered indeterminate in those
meeting only two. Overall, 178 (76%) of our patients met one echocardiographic cutoff value for LVDD, 91 (39%)
met two and 7 (3%) three or more. Patients meeting three cutoffs values showed a signiﬁcant reduction in
maximal oxygen uptake (16 ± 3 vs. 19.6 ± 5ml/kg/min, p b .05), unlike those with indeterminate tests. In mul-
tiple regression analysis, meeting three cutoffs was associated with number of METS (ß = −2.2, p = .018).
In exploratory analysis, using two criteria based on cutoffs different from those proposed in the guidelines, we
identiﬁed groups with different EC.
Conclusions: The application of 2016 ASE/EACVI guidelines limited the prevalence of LVDD to 3%. This group
showed a clear reduction of the EC. New echocardiographic cutoff values proposed in this study allow us to
establish subgroups with different levels of EC.pital Universitario Arab
(A.M. Alonso-Gómez).
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Obesity1. Introduction
Left ventricular diastolic dysfunction (LVDD) is often found to be as-
sociated with obesity, hypertension and diabetes in studies assessing
individuals with these risk factors [1–5]. Echocardiography is the tool
most widely used in clinical practice for the diagnosis of LVDD and aa, c/ Jose
rom bias
r the CC BY-NCdocument backed by European and American Societies has recently
been published recommending cutoff values for diagnosing diastolic
dysfunction [6]. On the other hand, it has been suggested that diastolic
function abnormalities are associated with a reduction in exercise ca-
pacity (EC) in patients with no myocardial ischaemia [7] and that such
an association can also be found in populationswith diabetes, hyperten-
sion, and obesity [8,9]. The bestmethod for assessing EC of an individual
is a cardiopulmonary exercise test including direct measurement of
maximal oxygen uptake [10]. The objective of this study was twofold:
ﬁrst, to assess the prevalence of LVDD in a population with deﬁned
risk factors (obesity and metabolic syndrome), and second, to assess
whether there is an association between LVDD and EC, and if so, the-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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patients with different levels of EC.
2. Methods
2.1. Study population
This analysis is based on data obtained from participants in the
Vitoria (Spain) arm of the Predimed Plus trial at the time of inclusion.
This trial was a multicentre randomized parallel-group study on pri-
mary cardiovascular prevention comparing the effect on cardiovascular
morbidity and mortality of an intensive lifestyle intervention based
on a Mediterranean hypocaloric diet, increase in physical activity
and behavioural therapy (intervention group) and a non-intensive
intervention consisting of a Mediterranean diet without calorie re-
striction (control group) [11]. The inclusion criteria for this study
were being a man aged 55–75 years or woman aged 60–75 years
with overweight or obesity (body mass index ≥ 27 and b40 kg/m2),
meeting at least three of the ﬁve criteria for metabolic syndrome
with no evidence of cardiovascular disease and agreeing voluntarily
to participate [12]. The study was approved by the ethic committees
of all the collaborating hospitals and all participants gave written in-
formed consent prior to their inclusion. The study was registered in
the International Standard Randomized Controlled Trial register (with
reference number 89898870).
2.2. Echocardiographic assessment
All the examinationswere carried out in the left lateral decubitus po-
sitionwith a Vivid E9 BT11 system (GE Vingmed Ultrasound AS, Horten,
Norway), using a GE M5S-D Cardiac Sector Probe (1.5–4.5 MHz). The
measurements were made by a technician with extensive experience,
following a predeﬁned acquisition protocol, and assessed by a single
cardiologist specialized in echocardiography. The assessment involved
a conventional complete echocardiographic study following the cur-
rent guidelines, which includes measurement of the left atrium by
the biplane method [13]. We calculated the ejection fraction from
the ventricular volumes obtained using two orthogonal projections
(apical 2 and 4 chambers) according to Simpson's rule. This calcula-
tion was carried manually or semi-automatically with the Auto-EF
tool (EchoPAC version 110.1.1 BT11; GE Vingmed Ultrasound AS).
Pulsed wave Doppler at the mitral valve was used to record E and A
wave velocities and deceleration times. Tissue Doppler echocardiogra-
phy (with spectral analysis) was used to quantify the early (e′) veloci-
ties at the lateral and septal mitral annulus. The tricuspid valve
regurgitation velocity was calculated from the systolic right ventricular
to right atrial pressure gradient. The mass of the left ventricle was
estimated using the Devereux formula and the E/e′ ratio from dividing
the E wave velocity at the mitral valve by the average mitral annulus
velocity, e′ (obtained by calculating the mean of the lateral and septal
velocities).
2.3. Cardiopulmonary exercise test
Participants performed a symptom-limited peak exercise test on
a treadmill (General Electric model T2100) following the ramped
Bruce treadmill test protocol [14] with continuous electrocardiographic
monitoring. Expired gases were analysed with a spiroergometry sys-
tem (MetaLyzer 3B, Firmware Version 2.0, Cortex, Leipzig. Germany)
using software for metabolic testing (MetaSoft Studio, Cortex). The
maximum value reached during peak effort was considered the maxi-
mal oxygen uptake (VO2max). The exercise workload, expressed in
metabolic equivalents (METS), was provided by the system's software,
as was the expected VO2, based on Wasserman's equation [15,16].
Participants were invited to keep exercising until they felt too tired to
continue, allowing them to touch the bars of the machine but nothold onto them. Blood pressure and heart rate (HR) were recorded
every 3 min and at the end of the test. The criteria for stopping were
those usually recommended in clinical practice guidelines [17]. The
effort was considered maximal when patients reached a respiratory
exchange ratio ≥ 1.10. In addition, in the case of respiratory exchange ra-
tios between 1 and 1.10, an HR ≥ 90% of the maximal theoretical HR
(220 bpm – age in years) and/or a Borg score ≥ 17 [18,19] were consid-
ered to indicate that the effort had been sufﬁcient for patient inclusion
in the analysis.
2.4. Echocardiographic cutoff values for diastolic dysfunction
The presence of LVDD was investigated by echocardiography apply-
ing the algorithm proposed in the latest guidelines for the diagnosis of
diastolic dysfunction in patients with preserved ejection fraction [6].
Speciﬁcally, the following classiﬁcation is recommended: criterion 1,
ratio of the peak E wave velocity to the mean of the lateral and septal
mitral annular velocities N14; criterion 2, septal mitral annular e′
velocity b 7 cm/s or lateralmitral annular e′ velocity b 10 cm/s; criterion
3, peak tricuspid regurgitation velocity (TRV) N2.8 m/s; and criterion 4,
left atrial volume index (LAVI) N34 ml/m2. Patients meeting three or
four cutoff values satisfy diagnostic criteria for LVDD and individuals
meeting a single cutoff are considered to have normal diastolic function
while test results are considered indeterminate in those meeting two.
2.5. Statistical analysis
Quantitative data are expressed asmeans± standard deviations and
qualitative data as counts and percentages. The differences between
groups were assessed using χ2 and Student's t-tests or analysis of vari-
ance as appropriate. Forward stepwise multiple regression analysis
was used to identify independent factors associatedwith functional aer-
obic capacity (FAC) expressed as VO2max, in ml/kg/min, the number of
METS and cardiopulmonary exercise test duration (minutes). For this,
we ﬁrst calculated the relative weight of independent variables on the
dependent variable and then entered variables in the model starting
with those with the greatest weight. Variables were retained in the
ﬁnal model if found to be statistically signiﬁcant or they caused a signif-
icant change in the rest of the coefﬁcients when removed. The results
are expressed as B coefﬁcients, p values and 95% conﬁdence intervals.
The diagnostic accuracy of LVDD echocardiographic criteria was evalu-
ated using as gold standard not to exceed 85% of maximum exercise
capacity. For this purpose, ROC curveswere created for four parameters:
85% theoretical maximal oxygen uptake (VO2max ml/kg/min), number
of mets, duration inminutes and 85% of themaximum theoretical aero-
bic functional capacity. The sensitivity, speciﬁcity, positive predictive
value and negative predictive value of each criterion were calculated.
The area under the curve (AUC) was also calculated as well as a cut-
off point for which these values were maximums. With these data
new thresholds were proposed for each of the echocardiographic
criteria and it was calculatedwhether the association of two criteria dis-
criminated groups of patients with signiﬁcantly different maximum
CFA. The statistical analysis was performed using IBM SPSS Statistics
for Windows, version 23, and R2.5. In all cases, p values b.05 were con-
sidered statistically signiﬁcant.
3. Results
3.1. Study population
We included 235 patients whomet the inclusion criteria, had a sinus
rhythm and had an ejection fraction above 50%. Their mean age was
65±5 years old and 78werewomen (33%). Table 1 summarises the de-
mographic information as well as blood and echocardiographic test re-
sults. Notably, the mean body mass index was 31.5 ± 3.4 kg/m2, high
percentages of the group had hypertension (84%) and hyperlipidaemia
Table 1
Characteristics of the study population.
Patients (n) 235
Age (years) 65 ± 5
Women (n, %) 78 (33%)
Body weight (kg) 87 ± 12
Height (cm) 166 ± 8
Body surface area, m2 1.95 ± 0.17
Body mass index (kg/m2) 31.5 ± 3.4
Systolic blood pressure (mm Hg) 149 ± 19
Diastolic blood pressure (mm Hg) 83 ± 10
History of smoking (last 5 years) 33 (14%)
Hypertension 197 (84%)
Diabetes 52 (22%)
Hyperlipidaemia 162 (69%)
Glucose level (mg/dL) 113 ± 24
Total cholesterol level (mg/dL) 215 ± 34
High-density lipoprotein level (mg/dL) 46.4 ± 10
Low-density lipoprotein level (mg/dL) 132 ± 29
Triglyceride level (mg/dL) 187 ± 78
Left ventricular end-diastolic diameter (mm) 47.7 ± 4.6
Left ventricular end-systolic diameter (mm) 31.1 ± 4.7
Septum (mm) 11 ± 1.6
Posterior wall (mm) 9.7 ± 1.5
Left ventricular mass (g) 159.5 ± 42
Left ventricular mass index (g/m2) 81.4 ± 19
Left atrial area (cm2) 21.4 ± 4.8
Left atrial volume (ml) 68.9 ± 18
Left atrial volume index (ml/m2) 35.3 ± 8.4
Left ventricular end-diastolic volume (ml) 102.3 ± 25
Left ventricular end-systolic volume (ml) 40.5 ± 12
Left ventricular end-diastolic volume index (ml/m2) 52.3 ± 10
Left-ventricular tele-systolic volume index (ml/m2) 20.7 ± 5
Ejection fraction (%) 60.4 ± 4.2
Peak early mitral inﬂow velocity (E) (m/s) 0.68 ± 0.14
Peak late mitral inﬂow velocity (A) (m/s) 0.81 ± 0.14
E/A ratio 0.85 ± 0.2
Deceleration time (ms) 225.3 ± 51
Lateral mitral annular velocity, e′ (cm/s) 8.4 ± 2
Septal mitral annular velocity, e′ (cm/s) 6.7 ± 1.5
Mean E/e′ ratio 9.2 ± 2.2
Peak tricuspid regurgitation velocity (m/s) 2.4 ± 0.2
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tion fraction was above 60%, the E/A ratio was b1 and e´ velocities were
low. It was possible to measure the TRV in 104 patients (44%).Fig. 1. Number of patients meeting echocardiographic cutoff values for left ventricle diastolic
Echocardiography/European Association of Cardiovascular Imaging guidelines.3.2. Echocardiographic cutoff values for diastolic dysfunction in the whole
population
Fig. 1 shows the number of patients who met one, two, three or
four of the criteria. Considering patients who met a single cutoff, the
most commonwas that of criterion 2 (reducedmitral annular velocity),
this being met in 178 patients. Among those who met two cutoff
values, 88 individuals met criteria 2 and 4. The table also indicates
the prevalence of LVDD obtained following the guidelines: 3% of
patients were diagnosed with dysfunction and 58% of patients found
to have normal function, while test results were considered indetermi-
nate in the rest (39%).
3.3. Parameters of functional aerobic capacity
The mean duration of the cardiopulmonary exercise test was 9.3 ±
2.3 min, representing an exercise workload of 10 ± 2.4 METS. The
mean VO2max was 19.5 ± 4.8 ml/kg/min, corresponding to 94 ± 18%
of the theoretical maximal EC. Overall, 169 patients (72%) exceeded
85% of the theoretical FAC. The mean theoretical maximum HR in the
group was 90 ± 10% and 84% of patients reached ≥85% of theoretical
maximum HR.
3.4. Echocardiographic cutoff values for diastolic dysfunction, and
echocardiographic and exercise capacity data
Table 2 indicates differences in echocardiographic and EC parame-
ters depending on whether the population satisﬁed two or three of
the criteria proposed in the guidelines. For each parameter considered,
the upper and lower rows represent the values obtained among those
whodid not and didmeet the cutoff values respectively. The 91 patients
who met any two cutoff values for LVDD had a higher LAVI, a lower
mean e´ velocity and a higher E/e′ ratio. Nevertheless, there were no
signiﬁcant differences in EC. In the case of the seven patients who met
three cutoff values for diastolic dysfunction, differences reached signiﬁ-
cance for LAVI, E/e′ ratio and TRV. All the parameters used to assess EC,
namely, VO2max, number of METS and duration of the cardiopulmonary
exercise test, were signiﬁcantly lower in these patients, the differences
in absolute terms being notable.dysfunction and the prevalence of this condition according to 2016 American Society of
Table 2
Echocardiographic parameters and exercise capacity data depending on whether patients
met two or three criteria of the 2016 ASE/EACVI recommendations for diastolic
dysfunction.
2 criteria
(met by n = 91)
3 criteria
(met by n = 7)
Left ventricular end-diastolic
diameter (mm)
47.2 ± 4⁎
48.5 ± 5
47.7 ± 5
48.6 ± 5
Left ventricular end-systolic
diameter (mm)
30.6 ± 5⁎
31.9 ± 5
31 ± 5
34 ± 6
Septum (mm) 11 ± 1.5
11 ± 1.5
11 ± 1.6
11.9 ± 1.2
Posterior wall (mm) 9.7 ± 1.5
9.6 ± 1.5
9.6 ± 1.5
10.6 ± 0.9
Left ventricular mass index (g/m2) 79 ± 17⁎
85 ± 20
81 ± 19&
94 ± 15
Left atrial area (cm2) 20 ± 5.3
23 ± 3.3
21 ± 5⁎
26 ± 3
Left atrial volume index (ml/m2) 31.5 ± 7⁎⁎⁎
41.2 ± 7
35 ± 8⁎⁎⁎
46 ± 7
Left ventricular end-diastolic volume
index (ml/m2)
52 ± 11
53 ± 10
52 ± 10
57.6 ± 13
Left ventricular end-systolic volume
index (ml/m2)
20.6 ± 5
20.8 ± 5
20.6 ± 5
23 ± 7
Ejection fraction (%) 60 ± 4
60.6 ± 4
60 ± 4
60 ± 2
Peak early mitral inﬂow velocity (E) (m/s) 0.67 ± 0.1
0.69 ± 0.2
0.67 ± 0.1⁎⁎⁎
0.96 ± 0.1
Peak late mitral inﬂow velocity (A) (m/s) 0.80 ± 0.1
0.83 ± 0.1
0.81 ± 0.1⁎
0.94 ± 0.2
E/A ratio 0.86 ± 0.2
0.85 ± 0.2
0.85 ± 0.2⁎
1 ± 0.2
Deceleration time (ms) 221 ± 47
232 ± 56
226 ± 51
213 ± 35
Average of lateral and septal e′ velocities
(cm/s)
8 ± 2⁎⁎⁎
7 ± 1
7.6 ± 1.6
6.5 ± 1.1
Average E/e′ ratio 8.6 ± 1.8⁎⁎⁎
10 ± 2
9 ± 2⁎⁎⁎
14.9 ± 2
TRV (m/s) 2.4 ± 0.2
2.4 ± 0.2
2.4 ± 0.2⁎⁎
2.7 ± 0.2
Maximum oxygen consumption
(ml/kg/min)
19.9 ± 4
18.9 ± 5
19.6 ± 5⁎
16 ± 3
Number of METS 10.2 ± 2
9.8 ± 2.5
10.1 ± 2⁎
7.9 ± 1.6
Exercise duration (min) 9.4 ± 2
9 ± 2
9.3 ± 2⁎
7.1 ± 1.7
For each parameter, the upper and lower values indicate the mean among patients who
did not and did meet the cutoff values.
& p: .076.
⁎ p b .05.
⁎⁎ p ≤ .01.
⁎⁎⁎ p ≤ .001.
Table 3
Exercise capacity multivariate analysis variables.
Variable B p-Value 95% conﬁdence
interval
R2
Maximal VO2 (ml/kg/min)
Sex −4.845 b.001 −6.230 to−3.460 0.444
Septal e′ velocity 0.332 .049 0.001–0.663
Age −0.204 b.001 −0.305 to−0.102
Left ventricular end-diastolic
diameter
0.135 .023 0.018–0.251
Body weight −0.277 b.001 −0.410 to−0.145
Body surface area 2.634 .021 1.883–23.385
METS
Sex −2.907 b.001 −3.723 to−2.091 0.437
Diabetes −1.424 b.001 −2.182 to−0.665
Met ≥3 recommended cutoffs
for diastolic dysfunction
−2.248 .018 −4.104 to−0.391
Age (years) −0.157 b.001 −0.223 to−0.090
Left ventricular end-diastolic
volume
−0.116 b.001 −0.161 to−0.071
Left ventricular end-diastolic
volume index
0.236 b.001 0.142–0.329
Smoking 0.353 .006 0.103–0.603
Left ventricular mass 0.010 .014 0.002–0.019
Cholesterol −0.966 .010 −1.701 to−0.230
Duration (min)
Sex −2.499 b.001 −3.224 to−1.773 0.382
Diabetes −1.047 .001 −1.640 to−0.453
Met ≥ 3 recommended cutoffs
for diastolic dysfunction
−1.511 .041 −2.960 to−0.062
Age (years) −0.111 b.001 −0.162 to−0.060
Height −0.077 .001 −0.121 to−0.033
Body mass index −0.186 b.001 −0.260 to−0.112
Left ventricular mass 0.009 .007 0.003–0.016
Table 4
Proposed new criteria for diastolic dysfunction and exercise capacity.
Criterion Number Maximal VO2
(ml/kg/min)
Number of METS Duration
(minutes)
E/e′ ratio ≥ 12 and
TRV ≥ 2.5 m/s
No: 182
Yes: 53
19.9 ± 4.7⁎⁎
18 ± 4.7
10.2 ± 2.3⁎⁎
9.1 ± 2.4
9.4 ± 2.3⁎⁎
8.4 ± 2.3
Average e′ b 8 cm/s
and LAVI N 36
No: 188
Yes: 47
19.9 ± 4.8⁎
18 ± 4.4
10.1 ± 2.4⁎
9.4 ± 2.3
9.4 ± 2.3⁎
8.6 ± 2.2
Mean e′ b 8 cm/s and
TRV ≥ 2.5 m/s
No: 217
Yes: 18
19.8 ± 4.7⁎⁎
16.2 ± 3.5
10.1 ± 2.3⁎⁎⁎
8.4 ± 2.3
9.3 ± 2.3⁎⁎
7.7 ± 2.2
TRV ≥ 2.5 m/s and
LAVI N 36
No: 220
Yes: 15
19.6 ± 4.7
17.9 ± 5.1
10.1 ± 2.3⁎
8.7 ± 2.6
9.3 ± 2.3
8.2 ± 2.7
E/e′ ratio ≥ 12 and
LAVI N 36
No: 225
Yes: 10
19.6 ± 4.7⁎
16.2 ± 3.8
10 ± 2.3⁎
8.3 ± 2.1
9.3 ± 2.3⁎
7.6 ± 2
TRV: peak tricuspid regurgitation velocity; LAVI: left atrial volume index.
⁎ p b .05.
⁎⁎ p ≤ .01.
⁎⁎⁎ p ≤ .005.
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variables
Table 3 presents the multiple regression models that best predicted
EC. None of the LVDD cutoff values were associated with VO2max, but
meeting three LVDD cutoffs was negatively associated with number of
METS (ß=−2.2, p= .018) and duration of the cardiopulmonary exer-
cise test (ß =−1.5, p = .041). Further, being diabetic was negatively
associated with EC.
3.6. Proposed new criteria for diastolic dysfunction and exercise capacity
In an attempt to improve the predictive capacity of the echocar-
diographic parameters for EC, we analysed a combination of two pa-
rameters using cutoff values that differed from those recommended
in the 2016 ASE/EACVI guidelines. Table 4 shows the proposed echo-
cardiographic cutoff values and how many patients met each crite-
rion. In all cases, there were signiﬁcant differences in some or all
the variables reﬂecting EC. The criterion of having an E/e′ ratio ≥ 12
and TRV ≥2.5 m/s was met by 23% of the patients and that of havinga mean e′ b 8 cm/s and LAVI N 36 by 20%, other combinations of cutoffs
being met by smaller subsets of patients. Table 5 compares the perfor-
mance of the new criteria and those proposed in the guidelines for diag-
nosing reduced FAC.
4. Discussion
The association between obesity and LVDDwasﬁrst identiﬁed a cou-
ple of decades ago and since then has been conﬁrmed in many studies,
using both invasive and non-invasive techniques. A pioneering study
carried out at the Mayo Clinic, studied 4281 patients without heart
disease, and found an association between a high body mass index
and elevated left ventricular end-diastolic pressure measured in a
haemodynamic study [1]. The largest body of evidence comes from
the use of echocardiography as a non-invasive technique, the relation-
ship between overweight and LVDD having being documented in
Table 5
Diagnostic accuracy of proposed new criteria and 2016 ASE/EACVI criteria for diagnosing reduced functional aerobic capacity.
TRV ≥ 2.5 m/s
E/e′ ≥ 12
Average e′ b 8 cm/s
LAVI N 36
Average e′ b 8 cm/s
TRV ≥ 2.5 m/s
E/e′ ≥ 12
LAVI N 36
TRV N 2.5 m/s
E/e′ ≥ 12
Two 2016
ASE/EACVI criteria
Three 2016
ASE/EACVI criteria
Sensitivity (%) 22.7 18.2 13.6 3.0 7.6 37.9 3
Speciﬁcity (%) 77.5 79.3 94.7 95.3 94.1 61 97
PPV (%) 28.3 25.5 50 20 33.3 27.5 28.6
NPV (%) 72 71.3 73.7 71.6 72.3 71.5 71.9
LAVI: left atrial volume index. NPV: negative predictive value. PPV: positive predictive value. TRV: peak tricuspid regurgitation velocity.
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risk factors [3] and N30,000 apparently healthy Koreans [4]. A high
prevalence of diastolic dysfunction has been found in patients diag-
nosed with diabetes or hypertension, reaching approximately 40%
in patients with diabetes [20], and ranging from 39 to 65% in those
with hypertension [21]. In this context, our population was expected
to have a high risk of LVDD, given that it included patients with a
mean body mass index in the obese range and 84% of patients had hy-
pertension and 22% diabetes.
4.1. Echocardiographic criteria for diastolic dysfunction
Three recent studies have analysed the validity of the recommen-
dations in the European Guidelines for detecting LVDD: in 241 patients
with a wide range of heart diseases, the diagnostic accuracy of echo-
cardiography reached 84% [22], in a multicentre European study of
120 patients with an ejection fraction N50%, the negative predictive
value was 93% [23] and in 90 patients from a single centre, it was con-
ﬁrmed that this algorithm provides a more accurate estimate of ﬁlling
pressures than previous guidelines [24]. A key ﬁnding of our study is
the conﬁrmation of high rates of patients who meet echocardiographic
cutoff values validated by the 2016 guidelines (Fig. 1). The single cut-
off that was most commonly met was that of a low e′ velocity, this
being met by 178 individuals, followed by left atrial enlargement,
and the pair of criteria most commonly met was that of these two
cutoff values. Our results are similar to ﬁndings in a population of in-
dividuals without heart disease [4] while the rates are lower than
those reported by Russo et al., although they applied less strict criteria
[2]. The population of the EPIPort study cohort is comparable to ours
except in that it had a higher mean age (62 vs 65 years old), lower
rates of hypertension (70 vs 84%) and diabetes (11 vs 22%), and only
25% of patients had obesity. Using the cutoff values from the European
guidelines, their results are in agreement with ours regarding the
percentage of patients that meet a single cutoff, and ﬁnally the preva-
lence of diastolic dysfunction was 1.4% [25] comparable to the 3%
found in our study.
4.2. Exercise capacity and diastolic dysfunction
It has been documented that diastolic dysfunction abnormalities are
independently associatedwith EC [26]. In 2867 patients without proven
coronary ischaemia, the presence of moderate-to-severe LVDD was an
independent predictor of functional aerobic capacity measured in
METS [7]. In our population, we also observed a signiﬁcant association
between deﬁnitely abnormal diastolic function (meeting three or
more of the cutoff values of the 2016 guidelines) and all the parameters
assessing the EC (Table 2). Declines in EC are related to numerous
factors, including increasing age, being female, a high body mass index
and several medical conditions such as diabetes and hypertension
[7–9]. In our study, the multiple regression analysis revealed an inde-
pendent association between these factors and EC, regardless of
whether it was measured in terms of VO2max, number of METS or car-
diopulmonary exercise test duration (Table 3). Deﬁnitely abnormal
left ventricle diastolic function was independently associated with two
parameters of functional capacity after adjusting the model for age,
sex and diabetes, in such a way that having this echocardiographicabnormality was associated with a two-fold higher likelihood of having
reduced EC.
4.3. Proposed cutoff values for diastolic dysfunction and exercise capacity
The LVDD is characterised by an impaired relaxation of the left ven-
tricle and loss of passive properties, which leads to an increase in ﬁlling
pressures and reduced cardiac output. In accordancewith the Fick prin-
ciple, cardiac output is linearly correlatedwithVO2max, and although the
determinants of VO2max are complex, it is agreed that heart involvement
can be a major etiological factor, and hence, it can be considered a sur-
rogate for left ventricular dysfunction, and in the case of normal ejection
fraction, the presence of diastolic dysfunction [27]. The association
between diastolic dysfunction and VO2max has also been conﬁrmed in
patients with dyspnoea [28] and heart valve disease [29]. Further, the
diagnosis of diastolic dysfunction in individuals with cardiovascular
risk factors and/or diabetes predicts the development of heart failure
[5,9,30] and this may be of great clinical relevance regarding the need
for aggressive management of this condition in such individuals.
Meeting the strict criteria of the 2016 guidelines conﬁrms LVDD,
but this occurs in a low percentage of patients. Indeed, ﬁndings
concerning LVDD were inconclusive in 39% of our study population,
and it is reasonable to think that some of themmay have had signiﬁcant
diastolic dysfunction. Seeking to improve this situation, we carried out
an exploratory analysis using the same parameters as those used in
the guidelines, but with different cutoff values. Meeting two new
criteria was associated with a signiﬁcant reduction in VO2max (Table 4)
suggesting the presence of diastolic dysfunction. An interesting
ﬁnding of our studywas that some of the proposed pairs of cutoff values
weremet in a signiﬁcant number of patients. For example, the E/e′ ratio
≥ 12 and TRV ≥2.5m/s cutoffs weremet by 22% of patients and themean
e′ b 8 cm/s and LAVI N36 ml cutoffs by 20% of patients. These results
are consistent with the literature, given that a high E/e′ ratio and the
presence of some degree of pulmonary hypertension are the most
widely used echocardiographic indices to establish the presence of
LVDD. If our ﬁndings were to be conﬁrmed, the usefulness in practical
terms of these new cutoff valuesmight be two-fold, since they are appli-
cable to a larger number of individuals and their diagnostic accuracy to
detect reduced FAC is similar to the most strict criteria of the 2016
guidelines (based on three cutoffs) and signiﬁcantly higher than that
of the criteria based on meeting two cutoffs (Table 5).
4.4. Study limitations
The sample size was relatively small, the data having been collected
at a single centre. The echocardiographic assessment of LVDD did not
include parameters other than those recommended in the 2016 ESC
guidelines, given that it was a recent strategy, validated by haemody-
namic studies, with an acceptable diagnostic accuracy, and that can be
implemented in the general population [24,25]. Although the reproduc-
ibility of echocardiographic measurements varies, the methodology
used ensured a low variability. We were not able to quantify the TRV
in all patients, but this is normal in populations with no heart disease.
The fact that it was not feasible to carry out a haemodynamic study,
considered the gold standard for diagnosing LVDD, led us to use
VO2max as a surrogate for diastolic dysfunction. Although peak VO2/kg
72 A.M. Alonso-Gómez et al. / IJC Heart & Vasculature 22 (2019) 67–72can be corrected for obese patients (given that body fat, which may
represent a signiﬁcant percentage of their total body mass, does not
consume oxygen during exercise), we did not attempt this, given that
there is no consensus on what type of correction should be applied
[31]. We have also included normal values for LAVI established for the
general population, even though it is known that normal levels of this
parameter can be higher in overweight individuals. The proposal of
new echocardiographic cutoff values for diastolic dysfunction is based
on exploratory analysis and the criteria require validation in further
studies and other populations.
5. Conclusions
The use of the strategy from the 2016 ASE/EACVI guidelines to diag-
nose LVDD with certainty limits the prevalence of diastolic dysfunction
to 3%. This group showed a clear reduction in EC assessed using VO2max.
New echocardiographic cutoff values proposed in this study allow us to
establish subgroups with different levels of EC.
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